Cargando…

IDO-induced immunosuppressive tryptophan catabolism following primary HIV infection

Detalles Bibliográficos
Autores principales:	Jenabian, Mohammad-Ali, Vyboh, Kishanda, Kema, Ido, Kanagaratham, Cynthia, Radzioch, Danuta, Gilmore, Norbert, Ancuta, Petronela, Tremblay, Cécile, Routy, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220858/ http://dx.doi.org/10.1186/1471-2334-14-S2-O14

Ejemplares similares

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2016)

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy
por: Mehraj, Vikram, et al.
Publicado: (2014)

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
por: Vyboh, Kishanda, et al.
Publicado: (2015)

Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans
por: Kiank, Cornelia, et al.
Publicado: (2010)

Regulatory T Cells in HIV Infection: Can Immunotherapy Regulate the Regulator?
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2012)

Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
por: Mehraj, Vikram, et al.
Publicado: (2015)

The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients
por: Lu, Wei, et al.
Publicado: (2015)

The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis
por: Wacleche, Vanessa Sue, et al.
Publicado: (2018)

Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
por: Kim, Minah, et al.
Publicado: (2021)

c-Src kinase is involved in the tyrosine phosphorylation and activity of SLC11A1 in differentiating macrophages
por: Xu, Yong Zhong, et al.
Publicado: (2018)

The Role of Placental Tryptophan Catabolism
por: Sedlmayr, Peter, et al.
Publicado: (2014)

Mouse Chromosome 4 Is Associated with the Baseline and Allergic IgE Phenotypes
por: Kanagaratham, Cynthia, et al.
Publicado: (2017)

Mapping of novel chromosomal regions associated with atopy
por: Kanagaratham, Cynthia, et al.
Publicado: (2014)

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART
por: DaFonseca, Sandrina, et al.
Publicado: (2015)

Tryptophan-Catabolizing Enzymes – Party of Three
por: Ball, Helen J., et al.
Publicado: (2014)

IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
por: Metz, Richard, et al.
Publicado: (2012)

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease
por: Sucher, Robert, et al.
Publicado: (2010)

Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
por: Munn, David H., et al.
Publicado: (1999)

Clinical significance of tryptophan catabolism in Hodgkin lymphoma
por: Masaki, Ayako, et al.
Publicado: (2017)

The therapeutic potential of targeting tryptophan catabolism in cancer
por: Opitz, Christiane A., et al.
Publicado: (2019)

Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies Peroxisome Proliferator-Activated Receptor Gamma as an intrinsic negative regulator of viral replication
por: Bernier, Annie, et al.
Publicado: (2013)

Mapping of a Chromosome 12 Region Associated with Airway Hyperresponsiveness in a Recombinant Congenic Mouse Strain and Selection of Potential Candidate Genes by Expression and Sequence Variation Analyses
por: Kanagaratham, Cynthia, et al.
Publicado: (2014)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome
por: Zhang, Jinlin, et al.
Publicado: (2022)

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107
por: Lodge, Robert, et al.
Publicado: (2020)

Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis
por: Zelante, Teresa, et al.
Publicado: (2014)

Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
por: Günther, Juliane, et al.
Publicado: (2019)

Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2
por: Lee, Young-Kwan, et al.
Publicado: (2014)

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship
por: Bortolotti, Perrine, et al.
Publicado: (2016)

Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease
por: Gulcev, Makedonka, et al.
Publicado: (2016)

Altered Tryptophan Catabolism in Placentas From Women With Pre-eclampsia
por: Keaton, Sarah A, et al.
Publicado: (2019)

Tryptophan catabolism and immune activation in primary and chronic HIV infection
por: Gelpi, Marco, et al.
Publicado: (2017)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
por: Peyraud, Florent, et al.
Publicado: (2022)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
por: Arinola, Ganiyu Olatunbosun, et al.
Publicado: (2023)

Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity
por: Cundy, Nicholas J., et al.
Publicado: (2021)

Tryptophan Intake and Tryptophan Losses in Hemodialysis Patients: A Balance Study
por: Post, Adrian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9dgapolnvlrc5cbgjrgvm2oe80